Physician profile
Tracy Miles
NPI 1225239106
$521.19
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $15.67 · 2021: $120 · 2022: $182.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $232.54 | 2021-2022 | |
| Amgen INC. | $56.59 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $46.99 | 2019 | |
| Emd Serono, INC. | $36.07 | 2022 | |
| Janssen Biotech, INC. | $24.20 | 2019 | |
| Varian Medical Systems, INC. | $17.11 | 2019 | |
| Pfizer INC. | $15.67 | 2020 | |
| Astellas Pharma US INC | $15.09 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.00 | 2019 | |
| Genentech USA, INC. | $12.82 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.54 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.44 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.23 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.